American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 32, Issue 1 , Pages 8-12 , January 2011

Study of protective effect on rat cochlear spiral ganglion after blast exposure by adenovirus-mediated human β-nerve growth factor gene

  • Jian Wu, MD

      Affiliations

    • Department of Otorhinolaryngology Head and Neck Surgery, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China
    • Corresponding Author InformationCorresponding author. Department of Otorhinolaryngology Head and Neck Surgery, Shanghai Changzheng Hospital, Second Military Medical University, 415 FengYang Road, Shanghai, 200003 China. Tel.: +86 021 81885962.
    • ,
  • Bing Liu, MD

      Affiliations

    • Department of Otorhinolaryngology Head and Neck Surgery, the Affiliated Hospital of Jining Medical College, Jining, Shangdong Province, China
    • ,
  • Jingping Fan, MD

      Affiliations

    • Department of Otorhinolaryngology Head and Neck Surgery, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China
    • ,
  • Qiubei Zhu, MD

      Affiliations

    • Department of Otorhinolaryngology Head and Neck Surgery, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China
    • ,
  • Jiang Wu, MD

      Affiliations

    • Department of Otorhinolaryngology Head and Neck Surgery, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China

Received 15 June 2009

References 

  1. Shoji F, Yamasoba T, Magal E, et al. Glial cell line-derive neurotrophic factor has a dose dependent influence on noise-induced hearing loss in the guinea pig cochlea. Hear Res. 2000;142:41–55
  2. Staecker H, Dazert S, Malgrange B, et al. Transforming growth factor alpha treatment alters intracellular calcium levels in hair cells and protects them from ototoxic damage in vivo. Int J Dev Neurosci. 1997;15:553–562
  3. Kawamoto K, Kanzaki S, Yagi M, et al. Gene-based therapy for the inner ear disease. Noise Health. 2001;3:37–47
  4. Yamasoba T, dolan DF. Chronic strychnine administration into the cochlea potentiates permanent threshold shift following noise exposure. Hear Res. 1997;112:13–20
  5. Ylikoski J, Pirvola U, Virkkala J, et al. Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear Res. 1998;124:17–26
  6. Zhai SQ, Guo W, Hu YY, et al. Protective effect of adenoviral mediated brain derived neurotrophic factor gene on spiral ganglion. Chin J Otorhinolaryngol. 2002;37:109–111
  7. Wu J, Sun AH, Fan JP, et al. Protective effects of nerve growth factor on blast exposure hearing damage in wistar rats. Chin J Nat Med Hyperbar Med. 2003;10:68–71
  8. Webster M, Webster DB. Spiral ganglion neuron loss following organ of corti loss: a quantitative study. Brain Res. 1981;212:17–30
  9. Miller JM, Chi D, O'Keeffe LJ, et al. Neurotrophins can enchance spiral ganglion cell survival after inner cell loss. Int J Dev Neurobiol. 1997;15:631–643
  10. Komeda M, Roessler BJ, Raphael Y. The influence of interleukin-1 receptor antagonist transgene on spiral ganglion neurons. Hear Res. 1999;123:1–10
  11. Nakaizumi T, Kawamoto K, Minoda R, et al. Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audio Neurootol. 2004;9:135–143
  12. Rejali D, Leev A, Abrashkin KA, et al. Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear Res. 2007;228:180–187
  13. Stover T, Yagi M, Raphael Y. Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer. Gene Ther. 2000;7:377–383
  14. Kawamoto K, Yagi M, Stover T, et al. Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF. Mol Ter. 2003;7:484–492
  15. Kawamoto K, Ishimoto SI, Minoda R, et al. Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosc. 2003;23:4395–4400
  16. Shen L, Figurov A, Lu B. Recent progress in studies of neurotrophic factors and their clinical implications. J Mol Med. 1997;75:637–644
  17. Lalwani AK, Walsh BJ, Carvalho GJ, et al. Expression of adeno-associated virus integrated transgene within the mammalian vestibular organs. Am J Otol. 1998;19:390–395
  18. Lalwani AK, Jero J, Mhatre AN. Current issues in cochlear gene transfer. Audio Neurootol. 2002;7:146–151
  19. Praetorius M, Brough DE, Hsu C, et al. Adenoviral vectors for improved gene delivery to the inner ear. Hear Res. 2009;248:31–38
  20. Stacker H, Li D, O'Malley BW, et al. Gene expression in the mammalian cochlea: a study of multiple vector systems. Acta Otolaryngol. 2001;121:157–163
  21. Yagi M, Kanzaki S, Kawamoto K, et al. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. Jo Assoc Res Otolaryngol. 2000;4:315–325
  22. Lalwani A, Walsh B, Reilly P, et al. Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus. Gene Ther. 1998;5:277–281
  23. Lalwani AK, Walsh BJ, Reilly PG, et al. Development of in vivo gene therapy for hearing disorder: introduction of adeno-associated virus into the Guinea pig. Gene Ther. 1996;3:588–592
  24. Kesser BN, Hashisaki GT, Holt JR. Gene transfer in human vestibular epithelia and the prospects for inner ear gene therapy. Laryngoscope. 2008;118:821–831
  25. Kesser BN, Hashisaki GT, Flectcher K, et al. An in vivo model system to study gene therapy in the human inner ear. Gene Ther. 2007;14:1121–1131

PII: S0196-0709(09)00167-7

doi: 10.1016/j.amjoto.2009.08.012

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 32, Issue 1 , Pages 8-12 , January 2011

Article Tools

* Image Usage & Resolution